These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12099329)

  • 1. Cardioprotection: what is it? Who needs it?
    Kannel WB
    Am J Manag Care; 2002 Jun; 8(9 Suppl):5-12. PubMed ID: 12099329
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease 2005--the global picture.
    Callow AD
    Vascul Pharmacol; 2006 Nov; 45(5):302-7. PubMed ID: 17074537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary salt reduction and cardiovascular disease.
    Nair M; Prabhakaran D
    Natl Med J India; 2010; 23(6):352-3. PubMed ID: 21561048
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed care considerations.
    Dunn JD
    Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S227-37. PubMed ID: 18611104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of illness among patients at high risk versus low risk for major cardiovascular events.
    Harley C; Sander SD; Zarotsky V; Cao F; Shah H
    J Med Econ; 2010; 13(3):438-46. PubMed ID: 20662626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high cost of couch potatoes.
    Chenoweth D; Pfohl S
    Bus Health; 2000 Jan; 18(1):20-2. PubMed ID: 10788135
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular manpower: the looming crisis.
    Bonow RO; Smith SC
    Circulation; 2004 Feb; 109(7):817-20. PubMed ID: 14981012
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertension: prevalence and economic implications.
    Dalzell MD
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):6-11. PubMed ID: 12971587
    [No Abstract]   [Full Text] [Related]  

  • 10. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
    Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
    Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of cardiovascular disease: a life every 32 seconds.
    Alspach JG
    Crit Care Nurse; 1991 Feb; 11(2):8, 10. PubMed ID: 2070629
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease in Mississippi.
    Jones ES; Carr AD
    J Miss State Med Assoc; 1995 Sep; 36(9):265-9. PubMed ID: 7473699
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of cardiovascular disease burden in the United States.
    Mensah GA; Brown DW
    Health Aff (Millwood); 2007; 26(1):38-48. PubMed ID: 17211012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth in use of lipid-lowering therapies: are we targeting the right patients?
    Dubois RW; Alexander CM; Wade S; Mosso A; Markson L; Lu JD; Nag S; Berger ML
    Am J Manag Care; 2002 Oct; 8(10):862-7. PubMed ID: 12395954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cardiovascular diseases:a medical-economic approach].
    Therapie; 2001; 56(2):125-30. PubMed ID: 11484713
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic kidney disease: the new silent killer.
    Kopyt NP
    J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.